Radiation-induced cardiovascular disease: an overlooked role for DNA methylation?

References

• Ratosa I, Ivanetic Pantar M. Cardiotoxicity of mediastinal radiotherapy. Rep Pract Oncol Radiother. 2019;24:629–643.
   Google Scholar
• Hoppe BS, Bates JE, Mendenhall NP, et al. The meaningless meaning of mean heart dose in mediastinal lymphoma in the modern radiation therapy era. Pract Radiat Oncol. 2020;10(3):e147–54.
   Google Scholar
• Van Nimwegen FA, Ntentas G, Darby SC, et al. Risk of heart failure in survivors of Hodgkin lymphoma: effects of cardiac exposure to radiation and anthracyclines. Blood. 2017;129(16):2257–2265.
   Google Scholar
• Pohjola‐Sintonen S, Tötterman KJ, Salmo M, et al. Late cardiac effects of mediastinal radiotherapy in patients with Hodgkin’s disease. Cancer. 1987;60(1):31–37.
   Google Scholar
• Hahn E, Jiang H, Ng A, et al. Late cardiac toxicity after mediastinal radiation therapy for Hodgkin lymphoma: contributions of coronary artery and whole heart dose-volume variables to risk prediction. Int J Radiat Oncol Biol Phys. 2017 Aug 1;98(5):1116–1123.
   Google Scholar
• Darby SC, Ewertz M, McGale P, et al. Risk of ischemic heart disease in women after radiotherapy for breast cancer. N Engl J Med. 2013 Mar 14;368(11):987–998.
   Google Scholar
• Drost L, Yee C, Lam H, et al. A systematic review of heart dose in breast radiotherapy. Clin Breast Cancer. 2018 Oct 1;18(5):e819–24.
   Google Scholar
• Bogaard VAB, van Den, Ta BDP, Schaaf A, et al. Validation and modification of a prediction model for acute cardiac events in patients with breast cancer treated with radiotherapy based on three-dimensional dose distributions to cardiac substructures. J Clin Oncol. 2017 Apr 10;35(11):1171.
   Google Scholar
• Yu AF, Jones LW. Modulation of cardiovascular toxicity in Hodgkin lymphoma: potential role and mechanisms of aerobic training. Future Cardiol. 2015;11(4):441–452.
   Google Scholar
• Boyne DJ, Mickle AT, Brenner DR, et al. Long-term risk of cardiovascular mortality in lymphoma survivors: a systematic review and meta-analysis. Cancer Med. 2018;7(9):4801–4813.
   Google Scholar
• Muka T, Koromani F, Portilla E, et al. The role of epigenetic modifications in cardiovascular disease: a systematic review. Int J Cardiol. 2016 Jun 1;212:174–183.
   Google Scholar
• Zhong J, Agha G, Baccarelli AA. The role of DNA methylation in cardiovascular risk and disease: methodological aspects, study design, and data analysis for epidemiological studies. Circ Res. 2016 Jan 8;118(1):119–131.
   Google Scholar
• Loree J, Koturbash I, Kutanzi K, et al. Radiation-induced molecular changes in rat mammary tissue: possible implications for radiation-induced carcinogenesis. Int J Radiat Biol. 2006 Jan 3;82(11):805–815.
   Google Scholar
• Luzhna L, Ilnytskyy Y, Kovalchuk O. Mobilization of LINE-1 in irradiated mammary gland tissue may potentially contribute to low dose radiation-induced genomic instability. Genes Cancer. 2015;6(1–2):71–81.
   Google Scholar
• Pogribny I, Koturbash I, Tryndyak V, et al. Fractionated low-dose radiation exposure leads to accumulation of DNA damage and profound alterations in DNA and histone methylation in the murine thymus. Mol Cancer Res. 2005 Oct 1;3(10):553–561.
   Google Scholar
• Jangiam W, Udomtanakunchai C, Reungpatthanaphong P, et al. Late effects of low-dose radiation on the bone marrow, lung, and testis collected from the same exposed BALB/cJ Mice. Dose-Response. 2018 Oct 19;16(4):155932581881503.
   Google Scholar
• Desouky O, Ding N, Zhou G. Targeted and non-targeted effects of ionizing radiation. J Radiat Res Appl Sci. 2015 Apr 1;8(2):247–254.
   Google Scholar
• Baskar R, Dai J, Wenlong N, et al. Biological response of cancer cells to radiation treatment. Front Mol Biosci. 2014;1:24.
   Google Scholar
• Balaji K, Subramanian B, Yadav P, et al. Radiation therapy for breast cancer: literature review. Med Dosim. 2016;41(3):253–257.
   Google Scholar
• Darby SC, Cutter DJ, Boerma M, et al. Radiation-related heart disease: current knowledge and future prospects. Int J Radiat Oncol Biol Phys. 2010 Mar 1;76(3):656–665.
   Google Scholar
• Hayes AW. Principles and methods of toxicology. 5th ed. CRC Press; 2007.
   Google Scholar
• Citrin DE, Mitchell JB. Mechanisms of normal tissue injury from irradiation. Semin Radiat Oncol. 2017;27(4):316–324.
   Google Scholar
• De Ruysscher D, Niedermann G, Burnet NG, et al. Radiotherapy toxicity. Nat Rev Dis Prim. 2019 Dec 21;5(1):13.
   Google Scholar
• Spetz J, Moslehi J, Sarosiek K. Radiation-induced cardiovascular toxicity: mechanisms, prevention, and treatment. Curr Treat Options Cardio Med. 2018 Apr 20;20(4):31.
   Google Scholar
• Cui S, Li W, Lv X, et al. Folic acid supplementation delays atherosclerotic lesion development by modulating MCP1 and VEGF DNA methylation levels in vivo and in vitro. Int J Mol Sci. 2017 May 5;18(5):990.
   Google Scholar
• Cuomo JR, Javaheri SP, Sharma GK, et al. How to prevent and manage radiation-induced coronary artery disease. Heart. 2018;104(20):1647–1653.
   Google Scholar
• Armanious MA, Mohammadi H, Khodor S, et al. Cardiovascular effects of radiation therapy. Curr Prob Cancer. 2018;42:433–442.
   Google Scholar
• Tapio S. Pathology and biology of radiation-induced cardiac disease. J Radiat Res. 2016 Sep 1;57(5):439–448.
   Google Scholar
• Lancellotti P, Nkomo VT, Badano LP, et al. Expert consensus for multi-modality imaging evaluation of cardiovascular complications of radiotherapy in adults: a report from the european association of cardiovascular imaging and the American society of echocardiography. J Am Soc Echocardiogr. 2013;26(9):1013–1032.
   Google Scholar
• Cuomo JR, Sharma GK, Conger PD, et al. Novel concepts in radiation-induced cardiovascular disease. World J Cardiol. 2016 Sep 26;8(9):504–519.
   Google Scholar
• Taunk NK, Haffty BG, Kostis JB, et al. Radiation-induced heart disease: pathologic abnormalities and putative mechanisms. Front Oncol. 2015;5:39.
   Google Scholar
• Dorresteijn LD, Stewart FA, Boogerd W. Stroke as a late treatment effect of Hodgkin’s disease. J Clin Oncol. 2006;24(9):1480. DOI:https://doi.org/10.1200/JCO.2005.04.8538.
   Google Scholar
• Bowers DC, McNeil DE, Liu Y, et al. Stroke as a late treatment effect of Hodgkin’s disease: a report from the childhood cancer survivor study. J Clin Oncol. 2005 Sep 20;23(27):6508–6515.
   Google Scholar
• Plummer C, Henderson RD, O’Sullivan JD, et al. Ischemic stroke and transient ischemic attack after head and neck radiotherapy: a review. Stroke. 2011;42(9):2410–2418.
   Google Scholar
• Dorresteijn LDA, Kappelle AC, Scholz NMJ, et al. Increased carotid wall thickening after radiotherapy on the neck. Eur J Cancer. 2005 May 1;41(7):1026–1030.
   Google Scholar
• Yusuf SW, Venkatesulu BP, Mahadevan LS, et al. Radiation-induced cardiovascular disease: a clinical perspective. Front Cardiovasc Med. 2017;26:4.
   Google Scholar
• Baselet B, Rombouts C, Benotmane AM, et al. Cardiovascular diseases related to ionizing radiation: the risk of low-dose exposure (Review). Int J Mol Med. 2016 Dec 1;38(6):1623–1641.
   Google Scholar
• Heidenreich PA, Kapoor JR. Radiation induced heart disease. Heart. 2008 Nov 25;95(3):252–258.
   Google Scholar
• Gujral DM, Lloyd G, Bhattacharyya S. Radiation-induced valvular heart disease. Heart. 2016 Feb 15;102(4):269–276.
   Google Scholar
• Halle M, Hall P, Tornvall P. Cardiovascular disease associated with radiotherapy: activation of nuclear factor kappa-B. J Intern Med. 2011 May;269(5):469–477.
   Google Scholar
• Sylvester CB, Abe J, Patel ZS, et al. Radiation-induced cardiovascular disease: mechanisms and importance of linear energy transfer. Front Cardiovasc Med. 2018;5:5.
   Google Scholar
• Baselet B, Sonveaux P, Baatout S, et al. Pathological effects of ionizing radiation: endothelial activation and dysfunction. Cell Mol Life Sci. 2019;76:699–728.
   Google Scholar
• Li M, You L, Xue J, et al. Ionizing radiation-induced cellular senescence in normal, non-transformed cells and the involved DNA damage response: a mini review. Front Pharmacol. 2018;9:522.
   Google Scholar
• Wang H, Wei J, Zheng Q, et al. Radiation-induced heart disease: a review of classification, mechanism and prevention. Int J Biol Sci. 2019;15(10):2128–2138.
   Google Scholar
• Halle M, Gabrielsen A, Paulsson-Berne G, et al. Sustained inflammation due to nuclear factor-kappa B activation in irradiated human arteries. J Am Coll Cardiol. 2010 Mar 23;55(12):1227–1236.
   Google Scholar
• Zhao W, Robbins M. Inflammation and chronic oxidative stress in radiation-induced late normal tissue injury: therapeutic implications. Curr Med Chem. 2008 Dec 30;16(2):130–143.
   Google Scholar
• Lee Chuy K, Nahhas O, Dominic P, et al. Cardiovascular complications associated with mediastinal radiation. Curr Treat Options Cardiovasc Med. 2019;21(7):1–20.
   Google Scholar
• Gordon JW, Shaw JA, Kirshenbaum LA. Multiple facets of NF-κB in the heart: to be or not to NF-κB. Circ Res. 2011;108(9):1122–1132.
   Google Scholar
• Land WG. The role of damage-associated molecular patterns (DAMPs) in human diseases part II: dAMPs as diagnostics, prognostics and therapeutics in clinical medicine. Sultan Qaboos Univ Med J. 2015;15(2):e157–70.
   Google Scholar
• Parichatikanond W, Luangmonkong T, Mangmool S, et al. Therapeutic targets for the treatment of cardiac fibrosis and cancer: focusing on tgf-β Signaling. Front Cardiovasc Med. 2020;7:34.
   Google Scholar
• Wei J, Wang B, Wang H, et al. Radiation-induced normal tissue damage: oxidative stress and epigenetic mechanisms. Oxid Med Cell Longev. 2019;2019(4):1–11.
   Google Scholar
• Li X, Gong Y, Li D, et al. Low-dose radiation therapy promotes radiation pneumonitis by activating NLRP3 inflammasome. Int J Radiat Oncol Biol Phys. 2020 Jul 15;107(4):804–814.
   Google Scholar
• Huang S, Che J, Chu Q, et al. The role of NLRP3 inflammasome in radiation-induced cardiovascular injury. Front Cell Dev Biol. 2020;8:140.
   Google Scholar
• Mezzaroma E, Mikkelsen RB, Toldo S, et al. Role of interleukin-1 in radiation-induced cardiomyopathy. Mol Med. 2015;21(1):210–218.
   Google Scholar
• Christersdottir T, Pirault J, Gisterå A, et al. Prevention of radiotherapy-induced arterial inflammation by interleukin-1 blockade. Eur Heart J. 2019 Aug 7;40(30):2495–2503.
   Google Scholar
• Wang Y, Boerma M, Zhou D. Ionizing radiation-induced endothelial cell senescence and cardiovascular diseases. Radiat Res. 2016 Aug;186(2):153–161.
   Google Scholar
• Liu Y, Bloom SI, Donato AJ. The role of senescence, telomere dysfunction and shelterin in vascular aging. Microcirculation. 2019;26(2):e12487. DOI:https://doi.org/10.1111/micc.12487. Wiley Blackwell
   Google Scholar
• Ayouaz A, Raynaud C, Heride C, et al. Telomeres: hallmarks of radiosensitivity. Biochimie. 2008;90(1):60–72. DOI:https://doi.org/10.1016/j.biochi.2007.09.011.
   Google Scholar
• Lustig A, Shterev I, Geyer S, et al. Long term effects of radiation exposure on telomere lengths of leukocytes and its associated biomarkers among atomic-bomb survivors. Oncotarget. 2016;7(26):38989–38998.
   Google Scholar
• Minamino T, Komuro I. Role of telomere in endothelial dysfunction in atherosclerosis. Curr Opin Lipidol. 2002;13(5):537–543.
   Google Scholar
• Sugihara T, Hattori Y, Yamamoto Y, et al. Preferential impairment of nitric oxide-mediated endothelium-dependent relaxation in human cervical arteries after irradiation. Circulation. 1999 Aug 10;100(6):635–641.
   Google Scholar
• Beckman JA, Thakore A, Kalinowski BH, et al. Radiation therapy impairs endothelium-dependent vasodilation in humans. J Am Coll Cardiol. 2001 Mar 1;37(3):761–765.
   Google Scholar
• Pathak R, Cheema AK, Boca SM, et al. Modulation of radiation response by the tetrahydrobiopterin pathway. Antioxidants. 2015;4(1):68–81.
   Google Scholar
• Hong CW, Kim YM, Pyo H, et al. Involvement of inducible nitric oxide synthase in radiation-Induced vascular endothelial damage. J Radiat Res. 2013 Nov;54(6):1036–1042.
   Google Scholar
• Donato AJ, Morgan RG, Walker AE, et al. Cellular and molecular biology of aging endothelial cells. J Mol Cell Cardiol. 2015;89:122–135.
   Google Scholar
• Estrada-Garcı́a L, Carrera-Rotllan J, Puig-Parellada P. Effects of oxidative stress and antioxidant treatments on eicosanoid synthesis and lipid peroxidation in long term human umbilical vein endothelial cells culture. Prostaglandins Other Lipid Mediat. 2002;67(1):13–25.
   Google Scholar
• Fardid R, Najafi M, Salajegheh A, et al. Radiation-induced non-targeted effect in vivo: evaluation of cyclooygenase-2 and endothelin-1 gene expression in rat heart tissues. J Cancer Res Ther. 2017 Jan 1;13(1):51–55.
   Google Scholar
• Azzam EI, Jay-Gerin JP, Pain D. Ionizing radiation-induced metabolic oxidative stress and prolonged cell injury. Cancer Lett. 2012;327(1–2):48–60.
   Google Scholar
• Milliat F, François A, Isoir M, et al. Influence of endothelial cells on vascular smooth muscle cells phenotype after irradiation: implication in radiation-induced vascular damages. Am J Pathol. 2006;169(4):1484–1495.
   Google Scholar
• Curigliano G, Lenihan D, Fradley M, et al. Management of cardiac disease in cancer patients throughout oncological treatment: ESMO consensus recommendations. Ann Oncol. 2020;31(2):171–190.
   Google Scholar
• RON WAKSMAN, PAKALA R, ROY P, et al. Effect of clopidogrel on neointimal formation and inflammation in balloon-denuded and radiated hypercholesterolemic Rabbit iliac arteries. J Interv Cardiol. 2008;21(2):122–128.
   Google Scholar
• Hoving S, Heeneman S, Gijbels MJJ, et al. NO-donating aspirin and aspirin partially inhibit age-related atherosclerosis but not radiation-induced atherosclerosis in ApoE null mice. PLoS One. 2010;5(9):1–10.
   Google Scholar
• Hoving S, Heeneman S, Gijbels MJJ, et al. Anti-inflammatory and anti-thrombotic intervention strategies using atorvastatin, clopidogrel and knock-down of CD40L do not modify radiation-induced atherosclerosis in ApoE null mice. Radiother Oncol. 2011;101(1):100–108. DOI:https://doi.org/10.1016/j.radonc.2011.09.019.
   Google Scholar
• Portela A, Esteller M. Epigenetic modifications and human disease. Nat Biotechnol. 2010 Oct 13;28(10):1057–1068.
   Google Scholar
• Ren W, Gao L, Song J. Structural basis of DNMT1 and DNMT3A-mediated DNA methylation. Genes (Basel). 2018 Dec 11;9(12):620.
   Google Scholar
• Lövkvist C, Dodd IB, Sneppen K, et al. DNA methylation in human epigenomes depends on local topology of CpG sites. Nucleic Acids Res. 2016 Jun 20;44(11):5123–5132.
   Google Scholar
• Walsh CP, Xu GL. Cytosine methylation and DNA repair. In: Current topics in microbiology and immunology. Springer Verlag; 2006. p. 283–315.
   Google Scholar
• Moore LD, Le T, Fan G. DNA methylation and its basic function. Neuropsychopharmacology. 2013 Jan;38(1):23–38.
   Google Scholar
• Fryxell KJ, Moon W-J. CpG mutation rates in the human genome are highly dependent on local GC content. Mol Biol Evol. 2005 Mar 1;22(3):650–658.
   Google Scholar
• Carlberg C, Molnár F. DNA methylation. In: Human epigenomics. Singapore: Springer Singapore; 2018. p. 57–73.
   Google Scholar
• Romanov GA, Sukhoverov VS. Arginine CGA codons as a source of nonsense mutations: a possible role in multivariant gene expression, control of mRNA quality, and aging. Mol Genet Genomics. 2017 Oct 1;292(5):1013–1026.
   Google Scholar
• Strichman-Almashanu LZ, Lee RS, Onyango PO, et al. A genome-wide screen for normally methylated human CpG islands that can identify novel imprinted genes. Genome Res. 2002 Mar 20;12(4):543–554.
   Google Scholar
• Wu H, Zhang Y. Reversing DNA methylation: mechanisms, genomics, and biological functions. Cell. 2014;156(1–2):45–68.
   Google Scholar
• Sarda S, Das A, Vinson C, et al. Distal CpG islands can serve as alternative promoters to transcribe genes with silenced proximal promoters. Genome Res. 2017 Apr;27(4):553–566.
   Google Scholar
• Deaton AM, Bird A. CpG islands and the regulation of transcription. Genes Dev. 2011 May 15;25(10):1010–1022.
   Google Scholar
• Yang X, Han H, De Carvalho DD, et al. Gene body methylation can alter gene expression and is a therapeutic target in cancer. Cancer Cell. 2014 Oct;;26(4):577–590.
   Google Scholar
• Luo C, Hajkova P, Ecker JR. Dynamic DNA methylation: in the right place at the right time. Science. 2018;361(6409):1336–1340.
   Google Scholar
• Bird A. DNA methylation patterns and epigenetic memory. Genes Dev. 2002 Jan 1;16(1):6–21.
   Google Scholar
• Feng J, Fan G. Chapter- 4 the role of DNA methylation in the central nervous system and neuropsychiatric disorders. Nov Approaches to Stud Basal Ganglia Relat Neuropsychiatr Disord. 2009;89:67–84. http://www.sciencedirect.com/science/article/pii/S0074774209890041
   Google Scholar
• Klose RJ, Bird AP. Genomic DNA methylation: the mark and its mediators. Trends Biochem Sci. 2006 Feb 1;31(2):89–97.
   Google Scholar
• Ambrosi C, Manzo M, Baubec T. Dynamics and context-dependent roles of DNA methylation. J Mol Biol. 2017;429(10):1459–1475.
   Google Scholar
• Unoki M. Recent insights into the mechanisms of De novo and maintenance of DNA methylation in mammals. In: DNA methylation mechanism. IntechOpen; 2019.
   Google Scholar
• Bhutani N, Burns DM, Blau HM. DNA demethylation dynamics. Cell. 2011 Sep 16;146(6):866–872.
   Google Scholar
• Miousse IR, Shao L, Chang J, et al. Exposure to low-dose 56 Fe-ion radiation induces long-term epigenetic alterations in mouse bone marrow hematopoietic progenitor and stem cells. Radiat Res. 2014;182(1):92–101.
   Google Scholar
• Miousse IR, Chang J, Shao L, et al. Inter-strain differences in LINE-1 DNA methylation in the mouse hematopoietic system in response to exposure to ionizing radiation. Int J Mol Sci. 2017 Jul 4;18(7):1430.
   Google Scholar
• Kennedy EM, Powell DR, Li Z, et al. Galactic cosmic radiation induces persistent epigenome alterations relevant to human lung cancer. Sci Rep. 2018 Dec 1;8(1):1–14.
   Google Scholar
• Koturbash I, Pogribny I, Kovalchuk O. Stable loss of global DNA methylation in the radiation-target tissue—A possible mechanism contributing to radiation carcinogenesis?. Biochem Biophys Res Commun. 2005 Nov 18;337(2):526–533.
   Google Scholar
• Tawa R, Kimura Y KOMURAJ-I, MIYAMURA Y, et al. Effects of X-ray irradiation on genomic DNA methylation levels in mouse tissues. J Radiat Res. 1998 Dec;39(4):271–278.
   Google Scholar
• Miousse IR, Kutanzi KR, Koturbash I. Effects of ionizing radiation on DNA methylation: from experimental biology to clinical applications. Int J Radiat Biol. 2017 May;93(5):457–469.
   Google Scholar
• Chaudhry MA, Omaruddin RA. Differential DNA methylation alterations in radiation-sensitive and -resistant cells. DNA Cell Biol. 2012 Jun 1;31(6):908–916.
   Google Scholar
• Goetz W, Morgan MNM, Baulch JE. The effect of radiation quality on genomic DNA methylation profiles in irradiated human cell lines. Radiat Res. 2011 May;;175(5):575–587.
   Google Scholar
• Kalinich JF, Catravas GN, Snyder SL. The effect of γ radiation on DNA methylation. Radiat Res. 1989 Feb;;117(2):185.
   Google Scholar
• Kuhmann C, Weichenhan D, Rehli M, et al. DNA methylation changes in cells regrowing after fractioned ionizing radiation. Radiother Oncol. 2011 Oct 1;101(1):116–121.
   Google Scholar
• Wang J, Zhang Y, Xu K, et al. Genome-wide screen of DNA methylation changes induced by low dose X-ray radiation in mice. PLoS One. 2014;9(3):e90804.
   Google Scholar
• Koturbash I, Boyko A, Rodriguez-Juarez R, et al. Role of epigenetic effectors in maintenance of the long-term persistent bystander effect in spleen in vivo. Carcinogenesis. 2007 Aug 1;28(8):1831–1838.
   Google Scholar
• Kumar A, Rai PS, Upadhya R, et al. γ-radiation induces cellular sensitivity and aberrant methylation in human tumor cell lines. Int J Radiat Biol. 2011 Nov 7;87(11):1086–1096.
   Google Scholar
• Acharya MM, Baddour AAD, Kawashita T, et al. Epigenetic determinants of space radiation-induced cognitive dysfunction. Sci Rep. 2017 Feb 21;7(January):1–15.
   Google Scholar
• Antwih DA, Gabbara KM, Lancaster WD, et al. Radiation-induced epigenetic DNA methylation modification of radiation-response pathways. Epigenetics. 2013 Aug 27;8(8):839–848.
   Google Scholar
• Aypar U, Morgan WF, Baulch JE. Radiation-induced epigenetic alterations after low and high LET irradiations. Mutat Res Mol Mech Mutagen. 2011 Feb 10;707(1–2):24–33.
   Google Scholar
• Koturbash I, Miousse IR, Sridharan V, et al. Radiation-induced changes in DNA methylation of repetitive elements in the mouse heart. Mutat Res. 2016;787:43–53.
   Google Scholar
• Sengupta P. The laboratory rat: relating its age with human’s. Int J Prev Med. 2013;4(6):624–630.
   Google Scholar
• Dutta S, Sengupta P. Men and mice: relating their ages. Life Sci. 2016;152:244–248.
   Google Scholar
• Zheng Y, Joyce BT, Liu L, et al. Prediction of genome-wide DNA methylation in repetitive elements. Nucleic Acids Res. 2017 Sep 1;45(15):8697–8711.
   Google Scholar
• Kietzmann T, Petry A, Shvetsova A, et al. The epigenetic landscape related to reactive oxygen species formation in the cardiovascular system. Br J Pharmacol. 2017;174(12):1533–1554.
   Google Scholar
• Yara S, Lavoie J-C LE. Oxidative stress and DNA methylation regulation in the metabolic syndrome. Epigenomics. 2015 Apr;;7(2):283–300.
   Google Scholar
• Wu Q, Ni X. ROS-mediated DNA methylation pattern alterations in carcinogenesis. Curr Drug Targets. 2015;16(1):13–19.
   Google Scholar
• Lee S-J, Dimtchev A, Lavin MF, et al. A novel ionizing radiation-induced signaling pathway that activates the transcription factor NF-κB. Oncogene. 1998 Oct 9;17(14):1821–1826.
   Google Scholar
• Janssens S, Tschopp J. Signals from within: the DNA-damage-induced NF-κB response. Cell Death Differ. 2006 May 13;13(5):773–784.
   Google Scholar
• Hei TK, Zhou H, Chai Y, et al. Radiation induced non-targeted response: mechanism and potential clinical implications. Curr Mol Pharmacol. 2011 Jun;;4(2):96–105.
   Google Scholar
• Di Maggio F, Minafra L, Forte G, et al. Portrait of inflammatory response to ionizing radiation treatment. J Inflamm. 2015 Feb 18;12(1):14.
   Google Scholar
• Liu Y, Mayo MW, Nagji AS, et al. Phosphorylation of RelA/p65 promotes DNMT-1 recruitment to chromatin and represses transcription of the tumor metastasis suppressor gene BRMS1. Oncogene. 2012 Mar 18;31(9):1143–1154.
   Google Scholar
• Li Y, Deuring J, Peppelenbosch MP, et al. 6-induced DNMT1 activity mediates SOCS3 promoter hypermethylation in ulcerative colitis-related colorectal cancer. Carcinogenesis. 2012 Oct 1;33(10):1889–1896.
   Google Scholar
• Brasier AR. The nuclear factor- B-interleukin-6 signalling pathway mediating vascular inflammation. Cardiovasc Res. 2010 May 1;86(2):211–218.
   Google Scholar
• Metabolic, Endocrine, and Genitourinary Pathobiology. DNA Methyl transferase 1 reduces expression of SRD5A2 in the aging adult prostate. Am J Pathol. 2015;185(3):870–882. http://www.sciencedirect.com/science/article/pii/S0002944014006907
   Google Scholar
• Ghaznavi H, Mahmoodi K, Soltanpour MS. A preliminary study of the association between the ABCA1 gene promoter DNA methylation and coronary artery disease risk. Mol Biol Res Commun. 2018 Jun;7(2):59–65.
   Google Scholar
• Guay S-P, Légaré C, Houde -A-A, et al. Acetylsalicylic acid, aging and coronary artery disease are associated with ABCA1 DNA methylation in men. Clin Epigenetics. 2014 Jul 29;6(1):14.
   Google Scholar
• Zhou J, Chen L, Yang X, et al. Preliminary study of the relationship between promoter methylation of the ANGPTL2 gene and coronary heart disease. J Clin Lab Anal. 2018;21:e22702.
   Google Scholar
• Nguyen A, Mamarbachi M, Turcot V, et al. Lower methylation of the ANGPTL2 gene in leukocytes from post-acute coronary syndrome patients. PLoS One. 2016 Apr 21;11(4):e0153920.
   Google Scholar
• Yamada Y, Horibe H, Oguri M, et al. Identification of novel hyper- or hypomethylated CpG sites and genes associated with atherosclerotic plaque using an epigenome-wide association study. Int J Mol Med. 2018 Feb 2;41(5):2724–2732.
   Google Scholar
• Chen X, Jiang D, Xu L, et al. Elevated methylation of cyclin dependent kinase inhibitor 2B contributes to the risk of coronary heart disease in women. Exp Ther Med. 2018 Nov 2;17(1):205–213.
   Google Scholar
• Zhong J, Chen X, Wu N, et al. Catechol-O-methyltransferase promoter hypomethylation is associated with the risk of coronary heart disease. Exp Ther Med. 2016 Nov 1;12(5):3445–3449.
   Google Scholar
• Miao L, Yin R-X, Zhang Q-H, et al. Integrated DNA methylation and gene expression analysis in the pathogenesis of coronary artery disease. Aging (Albany NY). 2019 Mar 7;11(5):1486–1500.
   Google Scholar
• Niu -P-P, Cao Y, Gong T, et al. Hypermethylation of DDAH2 promoter contributes to the dysfunction of endothelial progenitor cells in coronary artery disease patients. J Transl Med. 2014 Jun 16;12(1):170.
   Google Scholar
• Post WS, Goldschmidt-Clermont PJ, Wilhide CC, et al. Methylation of the estrogen receptor gene is associated with aging and atherosclerosis in the cardiovascular system [Internet]. Cardiovasc Res Narnia. 1999 Sep;1(4):985–91.
   Google Scholar
• Min J, Weitian Z, Peng C, et al. Correlation between insulin-induced estrogen receptor methylation and atherosclerosis. Cardiovasc Diabetol. 2016 Dec 10;15(1):156.
   Google Scholar
• Breitling LP, Salzmann K, Rothenbacher D, et al. F2RL3 methylation, and prognosis in stable coronary heart disease. Eur Heart J. 2012 Nov 1;33(22):2841–2848.
   Google Scholar
• Guay S-P, Brisson D, Munger J, et al. ABCA1 gene promoter DNA methylation is associated with HDL particle profile and coronary artery disease in familial hypercholesterolemia. Epigenetics. 2012 May 27;7(5):464–472.
   Google Scholar
• Jia L, Zhu L, Wang JZ, et al. Methylation of FOXP3 in regulatory T cells is related to the severity of coronary artery disease. Atherosclerosis. 2013 Jun 1;228(2):346–352.
   Google Scholar
• C-X L, Xu R-D, Cao M, et al. FOXP3 demethylation as a means of identifying quantitative defects in regulatory T cells in acute coronary syndrome. Atherosclerosis. 2013 Jul 1;229(1):263–270.
   Google Scholar
• Xu LL, Zheng D, Wang L, et al. GCK gene-body hypomethylation is associated with the risk of coronary heart disease. Biomed Res Int. 2014 Feb 17;2014:151723.
   Google Scholar
• Fan R WANGW-J, Q-L ZHONG, S-W DUAN, et al. Aberrant methylation of the GCK gene body is associated with the risk of essential hypertension. Mol Med Rep. 2015 Aug 1;12(2):2390–2394.
   Google Scholar
• Indumathi B, Katkam SK, Krishna LSR, et al. Dual effect of IL-6-174 G/C polymorphism and promoter methylation in the risk of coronary artery disease among south indians. Indian J Clin Biochem. 2019 Apr 21;34(2):180–187.
   Google Scholar
• Bakshi C, Vijayvergiya R, Aberrant DV. DNA methylation of M1-macrophage genes in coronary artery disease. Sci Rep. 2019 Dec 5;9(1):1429.
   Google Scholar
• Ghose S, Ghosh S, Tanwar VS, et al. Investigating Coronary Artery Disease methylome through targeted bisulfite sequencing. Gene. 2019 Dec 30;721:144107.
   Google Scholar
• Afzali M, Nakhaee A, Tabatabaei SP, et al. Aberrant promoter methylation profile of Niemann-pick type C1 gene in cardiovascular disease. Iran Biomed J. 2013;17(2):77–83.
   Google Scholar
• Jiang D, Zheng D, Wang L, et al. Elevated PLA2G7 gene promoter methylation as a gender-specific marker of aging increases the risk of coronary heart disease in females. Oudejans C, editor. PLoS One. 2013 Mar 28;8(3):e59752.
   Google Scholar
• Wei L, Zhao S, Wang G, et al. SMAD7 methylation as a novel marker in atherosclerosis. Biochem Biophys Res Commun. 2018 Feb 5;496(2):700–705.
   Google Scholar
• S-C MA, H-P ZHANG, F-Q KONG, et al. Integration of gene expression and DNA methylation profiles provides a molecular subtype for risk assessment in atherosclerosis. Mol Med Rep. 2016 Jun 1;13(6):4791–4799.
   Google Scholar
• Nakatochi M, Ichihara S, Yamamoto K, et al. Epigenome-wide association of myocardial infarction with DNA methylation sites at loci related to cardiovascular disease.
   Google Scholar
• Guay S-P, Légaré C, Brisson D, et al. Epigenetic and genetic variations at the TNNT1 gene locus are associated with HDL-C levels and coronary artery disease. Epigenomics. 2016 Mar 7;8(3):359–371.
   Google Scholar
• Huang Y-S, Zhi Y-F, Wang S-R. Hypermethylation of estrogen receptor-α gene in atheromatosis patients and its correlation with homocysteine. Pathophysiology. 2009 Oct 1;16(4):259–265.
   Google Scholar
• Akinyemiju T, Do AN, Patki A, et al. Epigenome-wide association study of metabolic syndrome in African-American adults. Clin Epigenetics. 2018 Dec 10;10(1):49.
   Google Scholar
• ÅK H, Mendelson MM, Marioni RE, et al. Epigenetic patterns in blood associated with lipid traits predict incident coronary heart disease events and are enriched for results from genome-wide association studies. Circ Cardiovasc Genet. 2017 Jan;10(1):e001487.
   Google Scholar
• Peng P, Wang L, Yang X, et al. A preliminary study of the relationship between promoter methylation of the ABCG1, GALNT2 and HMGCR genes and coronary heart disease. Coleman WB, editor. PLoS One. 2014 Aug 1;9(8):e102265.
   Google Scholar
• Pfeiffer L, Wahl S, Pilling LC, et al. DNA methylation of lipid-related genes affects blood lipid levels. Circ Cardiovasc Genet. 2015 Apr;8(2):334–342.
   Google Scholar
• Istas G, Declerck K, Pudenz M, et al. Identification of differentially methylated BRCA1 and CRISP2 DNA regions as blood surrogate markers for cardiovascular disease. Sci Rep. 2017 Dec 11;7(1):1–14.
   Google Scholar
• Wang P, Shen C, Diao L, et al. Aberrant hypermethylation of aldehyde dehydrogenase 2 promoter upstream sequence in rats with experimental myocardial infarction. Biomed Res Int. 2015 Jan 5;2015:1–13.
   Google Scholar
• Glier MB, Green TJ, Devlin AM. Methyl nutrients, DNA methylation, and cardiovascular disease. Mol Nutr Food Res. 2014 Jan;58(1):172–182.
   Google Scholar
• Jiang D, Sun M, You L, et al. DNA methylation and hydroxymethylation are associated with the degree of coronary atherosclerosis in elderly patients with coronary heart disease. Life Sci. 2019 May 1;224:241–248.
   Google Scholar
• Kim M, Long TI, Arakawa K, et al. Methylation as a biomarker for cardiovascular disease risk. Bader JS, editor. PLoS One. 2010 Mar 15;5(3):e9692.
   Google Scholar
• Fernández-Sanlés A, Sayols-Baixeras S, Subirana I, et al. Association between DNA methylation and coronary heart disease or other atherosclerotic events: a systematic review. Atherosclerosis. 2017 Aug 1;263:325–333.
   Google Scholar
• Aavik E, Babu M, Ylä-Herttuala S. DNA methylation processes in atheosclerotic plaque. Atherosclerosis. 2019 Feb 1;281:168–179.
   Google Scholar
• Hai Z, Zuo W. Aberrant DNA methylation in the pathogenesis of atherosclerosis. Clin Chim Acta. 2016 May 1;456:69–74.
   Google Scholar
• Turunen MP, Aavik E, Ylä-Herttuala S. Epigenetics and atherosclerosis. Biochim Biophys Acta Gen Subj. 2009 Sep 1;1790(9):886–891.
   Google Scholar
• Hiltunen MO, Turunen MP, Häkkinen TP, et al. DNA hypomethylation and methyltransferase expression in atherosclerotic lesions. Vasc Med. 2002 Feb 3;7(1):5–11.
   Google Scholar
• Aavik E, Lumivuori H, Leppanen O, et al. Global DNA methylation analysis of human atherosclerotic plaques reveals extensive genomic hypomethylation and reactivation at imprinted locus 14q32 involving induction of a miRNA cluster. Eur Heart J. 2015 Apr 2;36(16):993–1000.
   Google Scholar
• Pogribny IP, Beland FA. DNA hypomethylation in the origin and pathogenesis of human diseases. Cell Mol Life Sci. 2009 Jul 27;66(14):2249–2261.
   Google Scholar
• Zaina SA, Garay-Sevilla ME, Hernández-González MA, et al. Extensive demethylation of normally hypermethylated CpG islands occurs in human atherosclerotic arteries. Int J Mol Med. 2010 Sep 21;26(5):691–700.
   Google Scholar
• Jiang Y, Zhang H, Sun T, et al. The comprehensive effects of hyperlipidemia and hyperhomocysteinemia on pathogenesis of atherosclerosis and DNA hypomethylation in Apo E-/- mice. Acta Biochim Biophys Sin (Shanghai). 2012 Oct 1;44(10):866–875.
   Google Scholar
• Zaina S, Heyn H, Carmona FJ, et al. DNA methylation map of human atherosclerosis. Circ Cardiovasc Genet. 2014 Oct 1;7(5):692–700.
   Google Scholar
• Lund G, Andersson L, Lauria M, et al. DNA methylation polymorphisms precede any histological sign of atherosclerosis in mice lacking apolipoprotein E. J Biol Chem. 2004 Jul 9;279(28):29147–29154.
   Google Scholar
• Wagner JR, Busche S, Ge B, et al. The relationship between DNA methylation, genetic and expression inter-individual variation in untransformed human fibroblasts. Genome Biol. 2014 Feb 20;15(2):R37.
   Google Scholar
• Maeder ML, Angstman JF, Richardson ME, et al. Targeted DNA demethylation and activation of endogenous genes using programmable TALE-TET1 fusion proteins. Nat Biotechnol. 2013 Dec;31(12):1137–1142.
   Google Scholar
• Lea AJ, Vockley CM, Johnston RA, et al. Genome-wide quantification of the effects of DNA methylation on human gene regulation. Elife. 2018;1:7.
   Google Scholar
• Anastasiadi D, Esteve-Codina A, Piferrer F. Consistent inverse correlation between DNA methylation of the first intron and gene expression across tissues and species. Epigene Chromat. 2018 Jun 29;11(1):37.
   Google Scholar
• Dunn J, Qiu H, Kim S, et al. Flow-dependent epigenetic DNA methylation regulates endothelial gene expression and atherosclerosis. The Journal of Clinical Investigation. 2014 Jul 1;124(7):3187–3199.
   Google Scholar
• Cao Q, Wang X, Jia L, et al. Inhibiting DNA methylation by 5-Aza-2ⴕ- deoxycytidine ameliorates atherosclerosis through suppressing macrophage inflammation. Endocrinology. 2014 Dec 1;155(12):4925–4938.
   Google Scholar
• Calkin AC, Tontonoz P. Liver X receptor signaling pathways and atherosclerosis. Arterioscler Thromb Vasc Biol. 2010;30(8):1513–1518.
   Google Scholar
• Grbić E, Peterlin A, Kunej T, et al. PPARγ gene and atherosclerosis: genetic polymorphisms, epigenetics and therapeutic implications. Balk J Med Genet. 2018;21(1):39–46.
   Google Scholar
• Yu J, Qiu Y, Yang J, et al. DNMT1-PPARγ pathway in macrophages regulates chronic inflammation and atherosclerosis development in mice. Sci Rep. 2016;17:6.
   Google Scholar
• Chistiakov DA, Orekhov AN, Bobryshev YV. Treatment of cardiovascular pathology with epigenetically active agents: focus on natural and synthetic inhibitors of DNA methylation and histone deacetylation. Int J Cardiol. 2017;227:66–82.
   Google Scholar
• Nicorescu I, Dallinga GM, de Winther MPJ, et al. Potential epigenetic therapeutics for atherosclerosis treatment. Atherosclerosis. 2019;281:189–197.
   Google Scholar
• Schiano C, Vietri MT, Grimaldi V, et al. Epigenetic-related therapeutic challenges in cardiovascular disease. Trends Pharmacol Sci. 2015 Apr 1;36(4):226–235.
   Google Scholar
• Thomas PD, Campbell MJ, Kejariwal A, et al. PANTHER: A library of protein families and subfamilies indexed by function. Genome Res. 2003 Sep 1;13(9):2129–2141.
   Google Scholar
• Mi H, Muruganujan A, Huang X, et al. Protocol Update for large-scale genome and gene function analysis with the PANTHER classification system (v14.0). Nat Protoc. 2019 Mar 1;14(3):703–721.
   Google Scholar
• Segiet OA, Piecuch A, Ł M, et al. Role of interleukins in heart failure with reduced ejection fraction. Anatol J Cardiol. 2019;22(6):287–299.
   Google Scholar
• Abbate A, Toldo S, Marchetti C, et al. Interleukin-1 and the inflammasome as therapeutic targets in cardiovascular disease. Circ Res. 2020 Apr;24(9):1260–1280.
   Google Scholar
• Rose NR. Critical cytokine pathways to cardiac inflammation. J Interferon Cytokine Res. 2011;31(10):705–710.
   Google Scholar
• Aoyagi T, Matsui T. Phosphoinositide-3 kinase signaling in cardiac hypertrophy and heart failure. Curr Pharm Des. 2011 Jul 11;17(18):1818–1824.
   Google Scholar
• Kitamura Y, Koide M, Akakabe Y, et al. Manipulation of cardiac phosphatidylinositol 3-kinase (PI3K)/Akt signaling by apoptosis regulator through modulating IAP expression (ARIA) regulates cardiomyocyte death during doxorubicin-induced cardiomyopathy. J Biol Chem. 2014 Jan 31;289(5):2788–2800.
   Google Scholar
• Hoyer FF, Nahrendorf M. Interferon-γregulates cardiac myeloid cells in myocardial infarction. Cardiovasc Res. 2019;115:1815–1816.
   Google Scholar
• Ferreira LRP. Interferon-γ and other inflammatory mediators in cardiomyocyte signaling during Chagas disease cardiomyopathy. World J Cardiol. 2014;6(8):782.
   Google Scholar
• Wagner MA, Siddiqui MAQ, The JAK. STAT pathway in hypertrophic stress signaling and genomic stress response. JAK-STAT. 2012 Apr;1(2):131–141.
   Google Scholar
• Barry SP, Townsend PA, Latchman DS, et al. Role of the JAK–STAT pathway in myocardial injury. Trends Mol Med. 2007 Feb 1;13(2):82–89.
   Google Scholar
• Goswami R. JAK-STAT Signaling in Diseases. 1st ed. Boca Raton: CRC Press; 2020.
   Google Scholar
• Ivashkiv LB. Crosstalk with the Jak-STAT pathway in inflammation. In: Jak-Stat signaling: from basics to disease. Springer-Verlag Wien; 2012. p. 353–70.
   Google Scholar
• Boshuizen MCS, de Winther MPJ. Interferons as essential modulators of atherosclerosis. Arterioscler Thromb Vasc Biol. 2015 Jul 27;35(7):1579–1588.
   Google Scholar
• Zhang J, Alcaide P, Liu L, et al. Regulation of endothelial cell adhesion molecule expression by mast cells, macrophages, and neutrophils. PLoS One. 2011;6:1.
   Google Scholar
• Whitman SC, Ravisankar P, Elam H, et al. Exogenous interferon-γ enhances atherosclerosis in apolipoprotein E-/- mice. Am J Pathol. 2000;157(6):1819–1824.
   Google Scholar
• Fougerat A, Gayral S, Malet N, et al. Phosphoinositide 3-kinases and their role in inflammation: potential clinical targets in atherosclerosis?. Clinical Science. 2009;116:791–804.
   Google Scholar
• Ghigo A, Li M. Phosphoinositide 3-kinase: friend and foe in cardiovascular disease. Front Pharmacol. 2015 Aug 13;6(Aug):169.
   Google Scholar
• Choi KH, Kim JE, Song NR, et al. Phosphoinositide 3-kinase is a novel target of piceatannol for inhibiting PDGF-BB-induced proliferation and migration in human aortic smooth muscle cells. Cardiovasc Res. 2010 Mar 1;85(4):836–844.
   Google Scholar
• Buckley ML, Williams JO, Chan Y-H, et al. The interleukin-33-mediated inhibition of expression of two key genes implicated in atherosclerosis in human macrophages requires MAP kinase, phosphoinositide 3-kinase and nuclear factor-κB signaling pathways. Sci Rep. 2019;9(1):11317.
   Google Scholar
• Libby P. Interleukin-1 beta as a target for atherosclerosis therapy: biological basis of CANTOS and beyond. J Am Coll Cardiol. 2017;70(18):2278–2289.
   Google Scholar
• Hartman J, Frishman WH. Inflammation and atherosclerosis: A review of the role of interleukin-6 in the development of atherosclerosis and the potential for targeted drug therapy. Cardiology in Review. 2014;22:147–151.
   Google Scholar
• Tian Y, Ling X, Chen D, et al. Interleukin‐36 receptor antagonist attenuates atherosclerosis development by inhibiting NLRP3 inflammasome. J Cell Physiol. 2020 Dec 2;235(12):9992–9996.
   Google Scholar
• Fatkhullina AR, Peshkova IO, Koltsova EK. The role of cytokines in the development of atherosclerosis. Biochemistry (Moscow). 2016;81:1358–1370.
   Google Scholar
• Von der Thüsen JH, Kuiper J, Van Berkel TJC, et al. Interleukins in atherosclerosis: molecular pathways and therapeutic potential. Pharmacol Rev. 2003;55:133–166.
   Google Scholar
• Wouters K, Deleye Y, Hannou SA, et al. The tumour suppressor CDKN2A/p16INK4a regulates adipogenesis and bone marrow-dependent development of perivascular adipose tissue. Diab Vasc Dis Res. 2017 Nov 1;14(6):516–524.
   Google Scholar
• Musa A, Shabeeb D. Radiation-induced heart diseases: protective effects of natural products. Med (B Aires). 2019 May 9;55(5):126.
   Google Scholar
• Kolivand S, Amini P, Saffar H, et al. Selenium-L-methionine modulates radiation injury and Duox1 and Duox2 upregulation in rat’s heart tissues. J Cardiovasc Thorac Res. 2019 Jun 27;11(2):121–126.
   Google Scholar
• Siddique AN, Nunna S, Rajavelu A, et al. Targeted methylation and gene silencing of VEGF-A in human cells by using a designed Dnmt3a-Dnmt3L single-chain fusion protein with increased DNA methylation activity. J Mol Biol. 2013 Feb 8;425(3):479–491.
   Google Scholar
• Xu X, Tao Y, Gao X, et al. A CRISPR-based approach for targeted DNA demethylation. Cell Discov. 2016 May 3;2(1):1–12.
   Google Scholar
• Hanzawa N, Hashimoto K, Yuan X, et al. Targeted DNA demethylation of the Fgf21 promoter by CRISPR/dCas9-mediated epigenome editing. Sci Rep. 2020 Dec 1;10(1):1–14.
   Google Scholar
• Tang C, Oram JF. The cell cholesterol exporter ABCA1 as a protector from cardiovascular disease and diabetes. Biochim Biophys Acta - Mol Cell Biol Lipids. 2009 Jul 1;1791(7):563–572.
   Google Scholar
• Rudel LL, Lee RG, Cockman TL. Acyl coenzyme a: cholesterol acyltransferase types 1 and 2: structure and function in atherosclerosis. Curr Opin Lipidol. 2001 Apr;12(2):121–127.
   Google Scholar
• Chen C-H, Budas GR, Churchill EN, et al. Activation of aldehyde dehydrogenase-2 reduces ischemic damage to the heart. Science. 2008 Sep 12;321(5895):1493–1495.
   Google Scholar
• Gong D, Zhang H, Hu S. Mitochondrial aldehyde dehydrogenase 2 activation and cardioprotection. J Mol Cell Cardiol. 2013 Feb 1;55:58–63.
   Google Scholar
• Yang M-Y, Wang Y-B, Han B, et al. Activation of aldehyde dehydrogenase 2 slows down the progression of atherosclerosis via attenuation of ER stress and apoptosis in smooth muscle cells. Acta Pharmacol Sin. 2018 Jan;39(1):48–58.
   Google Scholar
• Kadomatsu T, Endo M, Miyata K, et al. Diverse roles of ANGPTL2 in physiology and pathophysiology. Trends Endocrinol Metab. 2014 May 1;25(5):245–254.
   Google Scholar
• van Westerop LLM, Arts-de Jong M, Hoogerbrugge N, et al. Cardiovascular risk of BRCA1/2 mutation carriers: a review. Maturitas. 2016 Sep 1;91:135–139. DOI:https://doi.org/10.1016/j.maturitas.2016.06.012.
   Google Scholar
• Chen M, Ni J, Zhang Y, et al. ERAP75 functions as a coactivator to enhance estrogen receptor α transactivation in prostate stromal cells. Prostate. 2008 Sep 1;68(12):1273–1282.
   Google Scholar
• Papait R, Kunderfranco P, Stirparo GG, et al. Long noncoding RNA: a new player of heart failure?. J Cardiovasc Transl Res. 2013 Dec 9;6(6):876–883.
   Google Scholar
• Bastos P, Gomes T, Ribeiro L. Catechol-O-methyltransferase (COMT): an update on Its Role in Cancer, Neurological and Cardiovascular Diseases. Rev Physiol Biochem Pharmacol. 2017;173:1–39.
   Google Scholar
• Akhtar S, Gremse F, Kiessling F, et al. CXCL12 promotes the stabilization of atherosclerotic lesions mediated by smooth muscle progenitor cells in Apoe-deficient mice. Arterioscler Thromb Vasc Biol. 2013 Apr;33(4):679–686.
   Google Scholar
• Farouk SS, Rader DJ, Reilly MP, et al. CXCL12: a new player in coronary disease identified through human genetics. Trends Cardiovasc Med. 2010 Aug;20(6):204–209. DOI:https://doi.org/10.1016/j.tcm.2011.08.002.
   Google Scholar
• van der Vorst EPC, Döring Y, Weber C. Chemokines and their receptors in Atherosclerosis. J Mol Med. 2015 Sep 15;93(9):963–971.
   Google Scholar
• Zhang J, Liu J, Li Z, et al. Dysfunction of endothelial NO system originated from homocysteine-induced aberrant methylation pattern in promoter region of DDAH2 gene. Chin Med J (Engl). 2007 Dec 5;120(23):2132–2137.
   Google Scholar
• Menazza S, Murphy E. The expanding complexity of estrogen receptor signaling in the cardiovascular system. Circ Res. 2016 Mar 18;118(6):994–1007.
   Google Scholar
• Mahmoodzadeh S, Eder S, Nordmeyer J, et al. Estrogen receptor alpha up-regulation and redistribution in human heart failure. Faseb J. 2006 May 1;20(7):926–934.
   Google Scholar
• Deroo BJ, Korach KS. Estrogen receptors and human disease. J Clin Invest. 2006 Mar 1;116(3):561–570.
   Google Scholar
• Rothenbacher D, Koenig W, Brenner H. Comparison of N-terminal pro–B-natriuretic peptide, C-reactive protein, and creatinine clearance for prognosis in patients with known coronary heart disease. Arch Intern Med. 2006 Dec 11;166(22):2455.
   Google Scholar
• Zhang Y, Yang R, Burwinkel B, et al. 3 methylation as a biomarker of current and lifetime smoking exposures. Environ Health Perspect. 2014 Feb;122(2):131–137.
   Google Scholar
• Waters CE, Saldivar JC, Hosseini SA, et al. FHIT gene product: tumor suppressor and genome "caretaker&quot. Cell Mol Life Sci. 2014 Dec;71(23):4577–4587.
   Google Scholar
• Di Paola R, Marucci A, Trischitta V. GALNT2 effect on HDL-cholesterol and triglycerides levels in humans: evidence of pleiotropy?. Nutr Metab Cardiovasc Dis. 2017 Apr 1;27(4):281–282.
   Google Scholar
• Marucci A, Antonucci A, De Bonis C, et al. GALNT2 as a novel modulator of adipogenesis and adipocyte insulin signaling. Int J Obes. 2019 Apr;30.
   Google Scholar
• Webster RJ, Warrington NM, Weedon MN, et al. The association of common genetic variants in the APOA5, LPL and GCK genes with longitudinal changes in metabolic and cardiovascular traits. Diabetologia. 2009 Jan 19;52(1):106–114.
   Google Scholar
• Iynedjian PB. Molecular physiology of mammalian glucokinase. Cell Mol Life Sci. 2009 Jan 26;66(1):27–42.
   Google Scholar
• Tracy MR, Dormans JP, Kusumi K. Klippel-feil syndrome. Clin Orthop Relat Res. 2004 Jul;424:183–190.
   Google Scholar
• YAMADA Y, NISHIDA T, HORIBE H, et al. Identification of hypo- and hypermethylated genes related to atherosclerosis by a genome-wide analysis of DNA methylation. Int J Mol Med. 2014 May 1;33(5):1355–1363.
   Google Scholar
• Nova-Lampeti E, Aguilera V, Oporto K, et al. Hox genes in adult tissues and their role in endothelial cell differentiation and angiogenesis. In: Endothelial dysfunction - old concepts and new challenges. InTech; 2018.
   Google Scholar
• Gorski DH, Patel CV, Walsh K. Homeobox transcription factor regulation in the cardiovascular system. Trends Cardiovasc Med. 1993 Sep 1;3(5):184–190.
   Google Scholar
• Fontes JA, Rose NR, Čiháková D. The varying faces of IL-6: from cardiac protection to cardiac failure. Cytokine. 2015 Jul;74(1):62.
   Google Scholar
• van der Heijden T, Bot I, The KJ. IL-12 cytokine family in cardiovascular diseases. Cytokine. 2019 Oct 1;122:154188. DOI:https://doi.org/10.1016/j.cyto.2017.10.010.
   Google Scholar
• Umar S, van der Laarse A. Nitric oxide and nitric oxide synthase isoforms in the normal, hypertrophic, and failing heart. Mol Cell Biochem. 2010 Jan 19;333(1–2):191–201.
   Google Scholar
• Shah A. Inducible nitric oxide synthase and cardiovascular disease. Cardiovasc Res. 2000 Jan 1;45(1):148–155.
   Google Scholar
• Davies RW, Wells GA, Stewart AFR, et al. A genome-wide association study for coronary artery disease identifies a novel susceptibility locus in the major histocompatibility complex. Circ Cardiovasc Genet. 2012 Apr 1;5(2):217–225.
   Google Scholar
• Missala I, Kassner U, Steinhagen-Thiessen E, et al. Review of the association of lipoprotein(a) and autoimmune diseases and atherosclerosis. Int J Rheumatol. 2012 Dec 5;2012:480784.
   Google Scholar
• Clarke R, Peden JF, Hopewell JC, et al. Genetic variants associated with Lp(a) lipoprotein level and coronary disease. N Engl J Med. 2009 Dec 24;361(26):2518–2528.
   Google Scholar
• Rozanski A, Takano APC, Kato PN, et al. M-protein is down-regulated in cardiac hypertrophy driven by thyroid hormone in rats. Mol Endocrinol. 2013 Dec;27(12):2055–2065.
   Google Scholar
• Sequeira V, Nijenkamp LLA, Regan JA, van der Velden J. The physiological role of cardiac cytoskeleton and its alterations in heart failure. Biochim Biophys Acta - Biomembr. 2014 Feb 1;1838(2):700–722.
   Google Scholar
• Liu X, Xu H, Xu H, et al. New genetic variants associated with major adverse cardiovascular events in patients with acute coronary syndromes and treated with clopidogrel and aspirin. bioRxiv. 2018;9:411165.
   Google Scholar
• Forstermann U, Sessa WC. Nitric oxide synthases: regulation and function. Eur Heart J. 2012 Apr 1;33(7):829–837.
   Google Scholar
• Yu X-H, Jiang N, Yao P-B, et al. NPC1, intracellular cholesterol trafficking and atherosclerosis. Clin Chim Acta. 2014 Feb 15;429:69–75.
   Google Scholar
• Sutton BS, Crosslin DR, Shah SH, et al. Comprehensive genetic analysis of the platelet activating factor acetylhydrolase (PLA2G7) gene and cardiovascular disease in case–control and family datasets. Hum Mol Genet. 2008 May 1;17(9):1318–1328.
   Google Scholar
• Karabina S, Ninio E. Plasma PAFAH/PLA2G7 genetic variability, cardiovascular disease, and clinical trials. Enzymes. 2015;38:145–155.
   Google Scholar
• Sorrentino S. The eight human “canonical” ribonucleases: molecular diversity, catalytic properties, and special biological actions of the enzyme proteins. FEBS Lett. 2010 Jun 3;584(11):2194–2200.
   Google Scholar
• Koczera P, Martin L, Marx G, et al. The ribonuclease a superfamily in humans: canonical RNases as the buttress of innate immunity. Int J Mol Sci. 2016 Aug 5;17(8):1278.
   Google Scholar
• Wei L, Chao N, Gao S, et al. Homocysteine induces vascular inflammatory response via SMAD7 hypermethylation in human umbilical vein smooth muscle cells. Microvasc Res. 2018 Nov 1;120:8–12.
   Google Scholar
• Papait R, Greco C, Kunderfranco P, et al. Epigenetics: a new mechanism of regulation of heart failure?. Basic Res Cardiol. 2013 Jul 6;108(4):361.
   Google Scholar
• Guo X, Wang X, Wang Y, et al. Variants in the SMARCA4 gene was associated with coronary heart disease susceptibility in Chinese han population. Oncotarget. 2017 Jan 31;8(5):7350.
   Google Scholar
• Chmielewski S, Piaszyk-Borychowska A, Wesoly J, et al. STAT1 and IRF8 in vascular inflammation and cardiovascular disease: diagnostic and therapeutic potential. Int Rev Immunol. 2016 Sep 2;35(5):434–454.
   Google Scholar
• Hammer S, Toenjes M, Lange M, et al. Characterization of TBX20 in human hearts and its regulation by TFAP2. J Cell Biochem. 2008 Jun 1;104(3):1022–1033.
   Google Scholar
• Shen T, Zhu Y, Patel J, et al. T-Box20 suppresses oxidized low-density lipoprotein-induced human vascular endothelial cell injury by upregulation of PPAR-γ. Cell Physiol Biochem. 2013;32(5):1137–1150.
   Google Scholar
• Johnson JL. Metalloproteinases in atherosclerosis. Eur J Pharmacol. 2017 Dec 5;816:93–106.
   Google Scholar
• Guay S-P, Voisin G, Brisson D, et al. Epigenome-wide analysis in familial hypercholesterolemia identified new loci associated with high-density lipoprotein cholesterol concentration. Epigenomics. 2012 Dec;4(6):623–639.
   Google Scholar
• Li C, Wang F, Yang Y, et al. Significant association of SNP rs2106261 in the ZFHX3 gene with atrial fibrillation in a Chinese Han GeneID population. Hum Genet. 2011 Mar;129(3):239–246. DOI:https://doi.org/10.1007/s00439-010-0912-6.
   Google Scholar
• Kao Y-H, Hsu J-C, Chen Y-C, et al. ZFHX3 knockdown increases arrhythmogenesis and dysregulates calcium homeostasis in HL-1 atrial myocytes. Int J Cardiol. 2016 May 1;210:85–92.
   Google Scholar
• Xue Y, Shi N, Zhang B, et al. Genetic variant in ZFHX3 geneon 16q22 associated with risk of stroke in Chinese Han population. Int J Clin Exp Pathol. 2016;9:8650–8656.
   Google Scholar
• Liu C, Yao M-D, Li C-P, et al. Silencing of circular RNA-ZNF609 ameliorates vascular endothelial dysfunction. Theranostics. 2017;7(11):2863–2877. DOI:https://doi.org/10.7150/thno.19353.
   Google Scholar
• Lin T, Zhang X, Lu Y, et al. Identification of circular RNA related to inflammation-induced lymphangiogenesis by microarray analysis. DNA Cell Biol. 2019 Aug;38(8):887–894.
   Google Scholar